On-Demand: Adapting CDMO Capabilities to Support the Development and Commercialization of Orphan Drugs and Novel Therapies

Thursday, October 5th

10am ET | 3pm GMT | 7am PT

Watch the on-demand webinar

Join experts to enhance your understanding of leveraging CDMO capabilities for orphan drug and novel therapy development and commercialization

Register now to learn valuable information about:

  • The increasing influx of novel therapies and orphan drugs is reshaping the drug development pipeline
  • The growing necessity for small-scale Contract Development and Manufacturing Organization (CDMO) capabilities among sponsors
  • Learn about Cambrex's strategic expansion of laboratory and small-scale commercial manufacturing suites designed to cater to orphan and niche therapies
Register today

Register now to watch the on-demand webinar!

Our presenter will carry out a live Q&A, if you have any questions please let us know.
By completing this form you agree Cambrex and Citeline may contact you directly about industry news, products, services and events that may be of interest. This is subject to and Cambrex's privacy policy and Citeline's privacy policy.

Meet the Speakers

Dan Bowles, Ph.D.

Vice President and General Manager, Cambrex High Point

Shawn E. Conway, Ph.D.

Senior Director, Operations, Cambrex High Point

Pharma Ignite Inspire. Connect. Innovate.
Powered by

Copyright ©️ 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company. Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.